The Company develops, manufactures & markets medical devices that are used in interventional cardiology, peripheral interventions, vascular surgery, electrophysiology, neurovascular intervention, oncology, endoscopy, urology, gynecology & neuromodulation.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
255. Boston Scientific (NYSE: BSX) is bottoming. Target: $6-$7. Now is a good time to buy. I'll be voting on this with my caps points. Sure, it is cheap and it lacks catalysts. At this point, the catalyst is effectively a rhetorical question: "who is going to sell?" Since stock prices are a function of daily supply and demand, I expect that the lack of selling at these prices and the bottoming effect will drive the stock into my price range. Eventually, at prices low enough, investors kind of look around at each other and decide that selling doesn't make sense. At that point, you don't need catalysts for upside because you get a self-fulfilling bottoming prophecy that does it on its own.http://beta.fool.com/bradford86/2012/01/10/price-market-part-37/